20 January 2024 - The Progeria Research Foundation marks significant achievement as Zokinvy (lonafarnib) receives Japanese approval for the treatment of progeria and processing deficient progeroid laminopathies.

The Progeria Research Foundation today announced a new milestone with the approval of Zokinvy (lonafarnib) by the Japanese Ministry of Health, Labor and Welfare, for the treatment of progeria and processing deficient progeroid laminopathies.